Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Predictive Oncology Inc POAI

Healthcare Medical Devices
Predictive Oncology Inc. is a knowledge-driven company focused on applying artificial intelligence (AI) to support the development of cancer therapies. The Company operates through three segments: Pittsburgh, Birmingham, and Eagan. Pittsburgh segment provides services, which include the application of artificial intelligence (AI) using its proprietary biobank of 150,000 plus tumor samples... see more

Recent & Breaking News (NDAQ:POAI)

Predictive Oncology Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 5 days ago

Predictive Oncology to Report First Quarter 2024 Financial Results on Wednesday, May 15, 2024

GlobeNewswire 10 days ago

Predictive Oncology Announces Significant Progress with FluGen In the Development of First-of-Its-Kind Intranasal Flu Vaccine

GlobeNewswire April 30, 2024

Predictive Oncology Announces Abstract Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire April 24, 2024

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

GlobeNewswire March 28, 2024

Predictive Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire February 21, 2024

Predictive Oncology to Participate in Upcoming San Francisco Conferences

GlobeNewswire January 2, 2024

Predictive Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire November 14, 2023

Predictive Oncology Completes AI-driven Study of Ovarian Cancer with UPMC Magee-Womens Hospital

GlobeNewswire November 8, 2023

Predictive Oncology to Report Third Quarter 2023 Financial Results and Host Conference Call and Webcast on Tuesday, November 14, 2023

GlobeNewswire November 7, 2023

Predictive Oncology Reports Second Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire August 10, 2023

Predictive Oncology to Report Second Quarter 2023 Financial Results and Host Conference Call and Webcast on Thursday, August 10, 2023

GlobeNewswire August 3, 2023

Predictive Oncology Announces Relocation of Corporate Headquarters to Pittsburgh

GlobeNewswire July 18, 2023

Predictive Oncology Appoints Biopharmaceutical Finance Veteran Mr. Andrew Einhorn to its Business Advisory Board

GlobeNewswire June 27, 2023

Predictive Oncology Appoints Dr. Bernard A. Harris, Jr. to its Newly Formed Business Advisory Board

GlobeNewswire June 20, 2023

Predictive Oncology invited to present groundbreaking approach to drug discovery at the 2023 BIO International Convention

GlobeNewswire May 23, 2023

Predictive Oncology Reports First Quarter 2023 Financial Results and Provides Business Update

GlobeNewswire May 15, 2023

Predictive Oncology to Report First Quarter 2023 Financial Results and Host Conference Call and Webcast on May 15, 2023

GlobeNewswire May 8, 2023

Predictive Oncology Appoints Pharma, Biotech and Digital Health Veteran Veena Rao, PhD, MBA, to its Board of Directors

GlobeNewswire May 2, 2023

Predictive Oncology Announces Reverse Stock Split

GlobeNewswire April 20, 2023